Monica Rodolfo Selected Research

Polycomb Repressive Complex 2

10/2020

Enhancer of zeste 2 polycomb repressive complex 2 subunit polymorphisms in melanoma skin cancer risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monica Rodolfo Research Topics

Disease

46	Melanoma (Melanoma, Malignant) 01/2024 - 06/2004
33	Neoplasms (Cancer) 01/2024 - 07/2002
6	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2002
2	Disease Progression 01/2024 - 11/2022
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2015
2	Adenocarcinoma 08/2009 - 11/2002
2	Wilms Tumor (Wilm's Tumor) 01/2009 - 02/2008
2	Neuroblastoma 01/2008 - 10/2003
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Starvation 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Skin Neoplasms (Skin Cancer) 10/2020
1	Adenocarcinoma of Lung 12/2019
1	Hematologic Neoplasms (Hematological Malignancy) 03/2016
1	Carcinogenesis 10/2014
1	Nevus (Nevi) 05/2014
1	Dysplastic Nevus Syndrome (Dysplastic Nevus) 05/2014
1	Astrocytoma (Pilocytic Astrocytoma) 05/2014
1	Lymphatic Metastasis 08/2010

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2007
8	VemurafenibIBA 01/2024 - 12/2011
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2016
6	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024 - 11/2019
6	MicroRNAs (MicroRNA)IBA 01/2020 - 08/2010
5	Immune Checkpoint InhibitorsIBA 01/2024 - 12/2018
5	EnzymesIBA 01/2022 - 10/2003
4	Phosphotransferases (Kinase)IBA 01/2024 - 01/2015
4	CytokinesIBA 01/2016 - 01/2009
3	Drug CombinationsIBA 11/2022 - 06/2014
3	CholesterolIBA 01/2022 - 06/2005
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 01/2016
2	LipidsIBA 01/2024 - 01/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2024 - 01/2022
2	AntibodiesIBA 01/2024 - 10/2003
2	trametinibIBA 01/2024 - 11/2022
2	Peptides (Polypeptides)IBA 01/2023 - 10/2003
2	Ribonucleases (Ribonuclease)IBA 10/2022 - 01/2017
2	ORALIT (ORS)IBA 01/2019 - 12/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 01/2009
2	Small Interfering RNA (siRNA)IBA 12/2011 - 07/2006
2	AntigensIBA 07/2006 - 10/2003
1	Oleic Acid (Oleate)IBA 01/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2024
1	IpilimumabIBA 01/2024
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	KisspeptinsIBA 01/2023
1	Kisspeptin-1 ReceptorsIBA 01/2023
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 11/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2022
1	dabrafenibIBA 11/2022
1	2-5A-dependent ribonuclease (RNase L)IBA 10/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2022
1	Testosterone (Sustanon)FDA Link 10/2022
1	Hormones (Hormone)IBA 10/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 10/2022
1	AndrogensIBA 10/2022
1	Proto-Oncogene Proteins B-rafIBA 01/2022
1	avasimibeIBA 01/2022
1	Orlistat (Xenical)FDA Link 05/2021
1	Polycomb Repressive Complex 2IBA 10/2020
1	nutlin 3IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Long Noncoding RNAIBA 12/2019
1	CateninsIBA 11/2019
1	Type 1 Melanocortin ReceptorIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 12/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2016
1	honokiolIBA 03/2016
1	Oxygen (Dioxygen)IBA 03/2016
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 03/2016
1	1-methyl-1-piperidinomethane sulfonateIBA 02/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2016
1	Microphthalmia-Associated Transcription FactorIBA 02/2016
1	TrabectedinIBA 01/2015
1	ProstaglandinsIBA 10/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2014
1	Dinoprostone (PGE2)FDA Link 10/2014
1	Ligases (Synthetase)IBA 10/2014
1	Interleukin-6 (Interleukin 6)IBA 07/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 06/2014
1	LigandsIBA 06/2014
1	Histone Deacetylase InhibitorsIBA 06/2014
1	Temozolomide (Temodar)FDA LinkGeneric 06/2014
1	CC ChemokinesIBA 06/2014
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 06/2014
1	ChemokinesIBA 06/2014
1	Dihydrotachysterol (AT 10)IBA 05/2014
1	CD13 Antigens (Alanine Aminopeptidase)IBA 04/2012
1	Proton Pump InhibitorsIBA 07/2010
1	Antineoplastic Agents (Antineoplastics)IBA 07/2010
1	CaspasesIBA 07/2010
1	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2009

Therapy/Procedure

16	Therapeutics 01/2024 - 10/2003
7	Immunotherapy 01/2024 - 07/2014
2	Ligation 05/2014 - 11/2009
1	Bioreactors (Bioreactor) 01/2022
1	Duration of Therapy 12/2021
1	Immunomodulation 01/2021
1	Radiotherapy 05/2014